New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
Di Paolo D, Yang D, Pastorino F, Emionite L, Cilli M, Daga A, Destafanis E, Di Fiore A, Piaggio F, Brignole C, Xu X, Liang C, Gibbons J, Ponzoni M, Perri P.
Di Paolo D, et al. Among authors: ponzoni m.
Oncotarget. 2015 Oct 6;6(30):28774-89. doi: 10.18632/oncotarget.4342.
Oncotarget. 2015.
PMID: 26299615
Free PMC article.